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responders undergoing in vitro fertilization/intracytoplasmic sperm
injection-embryo transfer treatmentPoor ovarian response remains a tough and challenging topic
encountered during in vitro fertilization (IVF) [1,2]. Polyzos and col-
leagues [3] indicated that live birth rates were only 6.0% per cycle
and 9.9% per patient in poor ovarian responders (PORs) based on
the Bologna criteria. The Cochrane review published in 2010
concluded that there is insufﬁcient evidence to support the routine
use of any pituitary downregulation and ovarian stimulation proto-
cols in the management of PORs [4]. A randomized, controlled trial
comparing the use of a gonadotropin-releasing hormone (GnRH)
agonist long protocol, a GnRH agonist short protocol, and a GnRH
antagonist protocol in PORs revealed no signiﬁcant differences in
pregnancy outcomes [5]. However, Kuang and colleagues [6]
demonstrated a novel protocol of luteal phase ovarian stimulation
(LPOS) in normal responders with optimal pregnancy outcomes
and no cases of premature luteinizing hormone (LH) surge. In the
luteal phase, progesterone and estradiol secreted from the corpus
luteum have a negative feedback to suppress LH release [7]. There-
fore, it is reasonable to suggest that LPOSmay be a suitable regimen
for PORswho are easy to suffer from premature LH surge during the
follicular stimulation.
The study by Wei and colleagues [8] in the current issue of the
Taiwanese Journal of Obstetrics & Gynecology attempted to compare
the IVF outcomes between LPOS and GnRH antagonist regimens in
PORs. The authors concluded that LPOS is a feasible and possibly
better protocol for PORs when compared to the GnRH antagonist
protocol [8]. The authors observed that on the human choriogona-
dotropin trigger day, PORs in the LPOS group achieved signiﬁcantly
lower serum levels of LH than those in the GnRH antagonist group.
Moreover, a marked lower rate of LH  10 was noted in the LPOS
group (0%) than in the GnRH antagonist group (9.5%). However, to-
tal gonadotropin consumption and duration of stimulation in the
LPOS group were signiﬁcantly greater than those in the GnRH
antagonist group. Above all, the authors found that PORs in the
LPOS group obtained a signiﬁcantly higher pregnancy rate (46.4%)
than those in the GnRH antagonist group (overall, 25.8%;
p¼ 0.04) with the transfer of fresh embryos (22.9%, p¼ 0.03) and
the transfer of frozen embryos (29.6%, p¼ 0.15) [8]. By contrast,
the authors displayed that in the LPOS group, the retrieved oocyte
numbers in the luteal phase were signiﬁcantly higher than those in
the follicular phase [8].
AlthoughWei and colleagues [8] presented promising data with
regard to the use of LPOS for PORs, we have to interpret the datahttp://dx.doi.org/10.1016/j.tjog.2016.04.002
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(http://creativecommons.org/licenses/by-nc-nd/4.0/).carefully. First, the ‘LPOS’ in the study actually included LPOS alone
and double stimulations (combined follicular phase and luteal
phase stimulations), which rendered the group heterogeneous.
Furthermore, to compare double stimulations with a GnRH antag-
onist protocol (single stimulation) may be a bias. Second, in addi-
tion to the bias of comparison between frozen embryos and fresh
embryos, the authors compared frozen embryos between LPOS
and GnRH antagonist groups, which was also a bias. Generally,
good embryos are usually applied in the fresh embryos transfer.
The quality of the residual frozen embryos is usually poorer. Third,
the authors conducted different stimulation protocols of follicular
phase (mild stimulation or natural cycle) and luteal phase (stan-
dard stimulation) in the double stimulations, which may be why
more oocytes were retrieved from the luteal phase stimulation
than from the follicular phase stimulation. In fact, there are several
biases in the retrospective study. Therefore, we must be cautious
with explaining the data. Further large-scale randomized,
controlled studies are required to prove the results.
Accumulated evidence showed thatmultiple waves of antral fol-
licles develop during the human menstrual cycle [9]. Several
studies substantiated that antral follicles at the luteal phase are
able to grow to maturity under proper ovarian stimulation
[10,11]. First of all, LPOS was applied for cancer patients. Von Wolff
et al [12] reported that there are no signiﬁcant differences in
numbers of aspirated oocytes, metaphase II oocyte rates, and fertil-
ization rates between follicular and luteal phase stimulations in
cancer patients. A retrospective cohort study conducted by Cakmak
and colleagues [13] disclosed that the number of total and mature
oocytes retrieved, oocyte maturity rate, and fertilization rates were
similar in random-start (late follicular phase or luteal phase) and
conventional-start (early follicular phase) cycles in the cancer pa-
tients. Kuang and coworkers [6] ﬁrst performed LPOS in normal re-
sponders and concluded that LPOS is a feasible and effective
approach of ovarian stimulationwith optimal pregnancy outcomes.
Additionally, a prospective comparative study revealed that donor
oocytes obtained after ovarian stimulation initiated on Day 2 or
Day 15 of the cycle achieved similar IVF outcomes [14]. Kuang
and colleagues [15] ﬁrst developed double stimulations for PORs
and demonstrated that double stimulations provide more opportu-
nities for retrieving oocytes during a short period in PORs. When
compared to the traditional antagonist protocol, LPOS achieved bet-
ter IVF outcomes in PORs in the study of Wei et al [8]. However,y Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND license
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and optimal stimulation protocol in LPOS.
In summary, different stimulation protocols are one of the stra-
tegies which attempt to improve clinical outcomes of PORs. Howev-
er, the effective and appropriate regimen for PORs remains
controversial in previous studies. A novel protocol of LPOS is
regarded as a potential better one in the management of PORs.
Wei and colleagues [8] indicated that the LPOS protocol enhanced
IVF outcomes compared with the GnRH antagonist protocol in
PORs. However, further large-scale randomized, controlled studies
are required to conﬁrm the efﬁcacy of LPOS in PORs and to investi-
gate an ideal stimulation protocol in LPOS.
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